Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,530

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,530 results for “choices”

Learn how ShareScore rates datasets ↗
dryad36/100

A nutrition-defense tradeoff drives diet choice in a toxic plant generalist

<p>Plant toxicity shapes the dietary choices of herbivores. Especially when herbivores sequester plant toxins, they may experience a tradeoff between gaining protection from natural enemies and avoiding toxicity. The availability of toxins for sequestration may additionally trade off with the nutritional quality of a potential food source for sequestering herbivores. We hypothesized that diet mixing might allow a sequestering herbivore to balance nutrition and defense (via sequestration of plant toxins). Accordingly, here we address diet mixing and sequestration of large milkweed bugs (<em>Oncopeltus fasciatus</em>) when they have differential access to toxins (cardenolides) in their diet. In the absence of toxins from a preferred food (milkweed seeds), large milkweed bugs fed on nutritionally adequate non-toxic seeds, but supplemented their diet by feeding on nutritionally poor, but cardenolide-rich milkweed leaf and stem tissues. This dietary shift corresponded to reduced insect growth but facilitated sequestration of defensive toxins. Plant production of cardenolides was also substantially induced by bug feeding on leaf and stem tissues, perhaps benefitting this cardenolide-resistant herbivore. Thus, sequestration appears to drive diet mixing in this toxic plant generalist, even at the cost of feeding on nutritionally poor plant tissue.</p>

opencc-zeroJul 2023View details →
dryad36/100

Dataset:Female state and condition-dependent chemical signalling revealed by male choice of silk trails

<p class="MsoNormal"><span>We ask whether males of the nuptial gift-giving spider <em>Pisaura mirabilis</em> exert preferences for mates varying in their reproductive potential based on chemical information during mate search. Males were presented with binary trails consisting of silk lines and substrate-borne chemicals deposited while females were walking, from females varying in a) body condition (high vs. low), b) developmental state (subadult vs. adult) and c) mating state (unmated vs. mated). If female chemical signaling co-varies with individual state, we expect males to choose trails of females that are a) in higher body condition, indicating higher fecundity, b) adults, which can successfully reproduce, and c) unmated, to avoid sperm competition. </span><span>We show that female signaling is condition-dependent, with m</span><span>ales being</span><span> more likely to follow trails of higher body condition females, but not dependent on female mating state. Males also tended to prefer trails of adults over subadults. Choice did not depend on male individual body condition.</span></p>

opencc-zeroAug 2023View details →
dryad36/100

Data from: Male size does not affect the strength of male mate choice for high-quality females in Drosophila melanogaster

<p class="MsoNormal">Theory predicts that the strength of male mate choice should vary depending on male quality when higher-quality males receive greater fitness benefits from being choosy. This pattern extends to differences in male body size, with larger males often having stronger pre- and post-copulatory preferences than smaller males.We sought to determine whether large males and small males differ in the strength (or direction) of their preference for large, high-fecundity females using the fruit fly, <em>Drosophila melanogaster</em>. We measured male courtship preferences and mating duration to show that male body size had no impact on the strength of male mate choice; all males, regardless of their size, had equally strong preferences for large females. To understand the selective pressures shaping male mate choice in males of different sizes, we also measured the fitness benefits associated with preferring large females for both large and small males. Male body size did not affect the benefits that males received: large and small males were equally successful at mating with large females, received the same direct fitness benefits from mating with large females, and showed similar competitive fertilization success with large females. These findings provide insight into why the strength of male mate choice was not affected by male body size in this system. Our study highlights the importance of evaluating the benefits and costs of male mate choice across multiple males to predict when differences in male mate choice should occur.</p>

opencc-zeroSep 2023View details →
ClinicalTrials.gov36/100

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative L

ClinicalTrials.gov study NCT04576455. IPD Sharing: YES. Countries: 17. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence

ClinicalTrials.gov study NCT03021759. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up

ClinicalTrials.gov study NCT03275350. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Promoting Informed Choice for Breast Cancer Screening

ClinicalTrials.gov study NCT05376241. IPD Sharing: YES. Countries: 1. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

ClinicalTrials.gov study NCT02000622. IPD Sharing: YES. Countries: 19. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Childbirth Education Classes, Spousal Support, Birth Memory, Choice of the Birth Method, and Birth Satisfaction

ClinicalTrials.gov study NCT07072507. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II

ClinicalTrials.gov study NCT02996864. IPD Sharing: NO. Countries: 1. Publications: 15.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Informed Choice - Compass

ClinicalTrials.gov study NCT05246839. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With Hi

ClinicalTrials.gov study NCT04209855. IPD Sharing: Not stated. Countries: 21. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

ClinicalTrials.gov study NCT03070392. IPD Sharing: Not stated. Countries: 14. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

ClinicalTrials.gov study NCT01564784. IPD Sharing: YES. Countries: 20. Publications: 13.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemi

ClinicalTrials.gov study NCT04778397. IPD Sharing: NO. Countries: 15. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

ClinicalTrials.gov study NCT04764604. IPD Sharing: NO. Countries: 1. Publications: 20.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

ClinicalTrials.gov study NCT04975308. IPD Sharing: YES. Countries: 22. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

The Effect of Mobile App Counseling on Postpartum Contraception Choices and Use

ClinicalTrials.gov study NCT07251569. IPD Sharing: NO. Countries: 1. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

ClinicalTrials.gov study NCT02360319. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

ClinicalTrials.gov study NCT02041533. IPD Sharing: Not stated. Countries: 26. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.